Synthesis, crystal structure and pH dependent cytotoxicity of (SP-4-2)-bis(2-aminoethanolato-κ2N, O)platinum(II) -: a representative of novel pH sensitive anticancer platinum complexes

被引:44
作者
Galanski, MS [1 ]
Baumgartner, C
Meelich, K
Arion, VB
Fremuth, M
Jakupec, MA
Schluga, P
Hartinger, CG
Von Keyserlingk, NG
Keppler, BK
机构
[1] Univ Vienna, Inst Inorgan Chem, Waehringerstr 42, A-1090 Vienna, Austria
[2] Faustus Forschungs Compagnie Translat Canc Res Gm, D-04109 Leipzig, Germany
基金
奥地利科学基金会;
关键词
platinum complexes; anticancer agents; N; O-ligands; pH-sensitive cytotoxicity;
D O I
10.1016/j.ica.2004.04.003
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Solid tumors are often hypoxic and consequently the pH in the tumoral tissue is decreasing with increasing tumor size (pH 5.5-7.4 in solid tumors versus pH 7.4 in normal tissues). This marked difference in pH value is a problem for weak base organic drugs and could advantageously be used for the introduction of pH sensitive anticancer platinum drugs. Synthesis and structure determination of (SP-4-2)-bis(2-aminoethanolato-kappa(2)N, O)platinum(II), its binding behavior to 5'-GMP and its cytotoxicity against cisplatin sensitive cell lines under standard pH screening conditions (pH 7.4) as well as in acidified cell culture medium (PH 6.0) mimicking the conditions in a number of solid tumors is presented. There is evidence that this concept in anticancer platinum therapy, namely administration of rather unreactive drugs and activation under acidic pH conditions, can be realized. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:3237 / 3244
页数:8
相关论文
共 28 条
[1]  
[Anonymous], 1992, INT TABLES XRAY CRYS, VC
[2]   Bis(2-aminobutanol)dichloroplatinum(II) complexes and their singly and doubly ring-closed butanolato species - Novel prodrugs for platinum-based antitumour chemotherapy? [J].
Galanski, M ;
Baumgartner, C ;
Arion, V ;
Keppler, BK .
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, 2003, (14) :2619-2625
[3]  
Galanski MS, 2001, EUR J INORG CHEM, P1145, DOI 10.1002/1099-0682(200105)2001:5<1145::AID-EJIC1145>3.0.CO
[4]  
2-E
[5]   Tumor pH: Implications for treatment and novel drug design [J].
Gerweck, LE .
SEMINARS IN RADIATION ONCOLOGY, 1998, 8 (03) :176-182
[6]   The pH partition theory predicts the accumulation and toxicity of doxorubicin in normal and low-pH-adapted cells [J].
Gerweck, LE ;
Kozin, SV ;
Stocks, SJ .
BRITISH JOURNAL OF CANCER, 1999, 79 (5-6) :838-842
[7]   Tumor-inhibiting platinum(II) complexes with aminoalcohol ligands: Comparison of the mode of action by capillary electrophoresis and electrospray ionization-mass spectrometry [J].
Hartinger, CG ;
Schluga, P ;
Galanski, M ;
Baumgartner, C ;
Timerbaev, AR ;
Keppler, BK .
ELECTROPHORESIS, 2003, 24 (12-13) :2038-2044
[8]   Tumour-inhibiting platinum complexes-state of the art and future perspectives [J].
Jakupec, MA ;
Galanski, M ;
Keppler, BK .
REVIEWS OF PHYSIOLOGY, BIOCHEMISTRY AND PHARMACOLOGY, VOL 146, 2003, 146 :1-53
[9]   Structure, recognition, and processing of cisplatin-DNA adducts [J].
Jamieson, ER ;
Lippard, SJ .
CHEMICAL REVIEWS, 1999, 99 (09) :2467-2498
[10]  
Johnson C.K., 1976, Oak Ridge National Laboratory Report ORNL, P5138